Pharmaceutical
Pharmaceutical
Section actions for a nature-positive future
The pharmaceutical sector heavily relies on nature, but its global supply chains and manufacturing processes also contribute to pollution, emissions and nature loss. These actions guide companies to cut impacts, safeguard ecosystems and build more resilient value chains.
Overview
Many medicines originate from natural compounds, making biodiversity essential for pharmaceutical innovation and our general health and wellbeing. At the same time, the sector’s water use, emissions, waste, and chemical pollution contribute to pressures on ecosystems already stressed by climate change and resource exploitation.
As environmental risks intensify, nature loss poses challenges to supply security, manufacturing stability, and global health. Reducing emissions and pollution, improving water stewardship and sourcing materials responsibly will help safeguard both ecosystems and the long‑term resilience of the sector.
The sector actions serve as a guide to transform business practices and value chains so the pharmaceutical sector can play its part in halting and reversing nature loss by 2030 - the mission at the heart of the Global Biodiversity Framework.
The overview and report were led by Business for Nature and the World Business Council for Sustainable Development with support from PwC UK and with input from leading academic, industry, non-governmental organizations and government experts.
How the pharmaceutical sector impacts nature
Greenhouse gas emissions
Energy-heavy manufacturing and global distribution create significant greenhouse gas emissions that contribute to climate change.
Land use change
Sourcing natural raw materials can drive deforestation and degrade ecosystems.
Solid waste
Packaging, consumables and medical waste add to landfill pressure and environmental pollution.
Water use
Water-intensive production processes rely heavily on freshwater availability.
Water pollution
Active pharmaceutical ingredients and other chemicals entering waterways can disrupt aquatic species and ecosystem function.
What the sector depends on
Water supply
Clean, stable water sources are essential for manufacturing, formulation, and sanitation.
Water purification
Natural filtration processes help secure high-quality water vital for production.
Climate regulation
Reliable temperatures and weather conditions support research and development and global operations.
Genetic material research
Biodiverse ecosystems provide genetic resources foundational to drug discovery.
Bio-based products
Many ingredients and packaging materials come from renewable biological sources.
Five actions to drive systemwide transformation
1. Reduce water use
Improve efficiency across sites and processes to lower pressure on freshwater resources.
2. Reduce pollution risk from active pharmaceutical ingredients
Strengthen controls to prevent pharmaceutical chemicals from entering waterways and ecosystems.
3. Avoid and reduce greenhouse gas emissions across the value chain
Cut emissions from manufacturing, logistics and suppliers to support climate and nature goals.
4. Source responsibly and improve supply chain transparency
Track and reduce nature impacts from raw materials while scaling lower impact alternatives.
5. Reduce solid waste across the value chain
Minimize packaging, increase recyclability and prevent pollution from discarded medical products.
Download the resources
Download additional resources